Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The anti-inflammatory efficacy of melanocortin drugs is influenced by genetic variation at MC1R.

Scientific reports·2026
Same author

Resolution Pharmacology: State-of-the-art and therapeutic landscape.

Pharmacological reviews·2025
Same author

The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis.

Arthritis research & therapy·2025
Same author

Integrative Multi-PTM Proteomics Reveals Dynamic Global, Redox, Phosphorylation, and Acetylation Regulation in Cytokine-Treated Pancreatic Beta Cells.

Molecular & cellular proteomics : MCP·2025
Same author

Mitochondrial bioenergetics in resilience of older adults with gynecologic cancer: design and rationale of a pilot study.

GeroScience·2025
Same author

Mitochondrial Bioenergetics in Resilience of Older Adults with Gynecologic Cancer: Design and Rationale of a Pilot Study.

medRxiv : the preprint server for health sciences·2025
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
Same journal

Why and How Epstein-Barr Virus Was Discovered 50 Years Ago.

Current topics in microbiology and immunology·2026
See all related articles
  1. Home
  3. Resolution Pharmacology Targeting The Melanocortin System.
  1. Home
  3. Resolution Pharmacology Targeting The Melanocortin System.

Related Experiment Video

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Resolution Pharmacology Targeting the Melanocortin System.

Nicholas J Day1, Camilla S A Davan-Wetton1, Natalya Khodeneva1

  • 1The William Harvey Research Institute, Queen Mary University of London, London, UK.

Current Topics in Microbiology and Immunology
|May 18, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

New research focuses on the body's natural inflammation resolution mechanisms. Targeting the melanocortin system offers novel drug development opportunities for chronic inflammatory diseases.

Keywords:
Chronic inflammationGPCRsMelanocortin receptorsPrecision medicineResolution pharmacology

More Related Videos

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Experiment Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Area of Science:

  • Immunology
  • Pharmacology
  • Drug Discovery

Background:

  • Inflammation resolution is now understood as an active, coordinated process.
  • This understanding shifts therapeutic focus towards endogenous pro-resolving mechanisms.
  • The melanocortin system is a key endogenous pathway involved in inflammation resolution.

Purpose of the Study:

  • To explore the therapeutic potential of targeting the melanocortin system.
  • To review the development of novel molecules modulating the melanocortin system.
  • To identify future research directions for melanocortin-based therapies.

Main Methods:

  • Review of existing literature on inflammation resolution and the melanocortin system.
  • Analysis of drug development efforts targeting melanocortin receptors.
  • Synthesis of data on therapeutic applications and future research needs.

    • Main Results:

    • The melanocortin system, comprising five G-protein-coupled receptors and endogenous peptides, plays a crucial role in resolving inflammation.
    • Several melanocortin-based drugs are approved for treating inflammatory conditions like rheumatoid arthritis.
    • Ongoing research aims to develop improved molecules for enhanced therapeutic efficacy.

    Conclusions:

    • Targeting the melanocortin system represents a promising strategy for treating chronic inflammatory diseases.
    • Further development is needed to optimize melanocortin-based drug candidates.
    • Exploiting the body's pro-resolving mechanisms offers a pathway to novel anti-inflammatory medicines.